1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Orally Inhaled Corticosteroids to 2022

Orally Inhaled Corticosteroids to 2022

  • April 2015
  • -
  • Greystone Research Associates

Asthma continues to be a health segment that presents challenges to the caregiver community. Patient adherence with prescribing instructions and treatment protocols remains sub-optimal across all patient categories, but particularly for the young and the elderly. This has led to significant interest on the part of device and combination product providers directed toward the development easier-to-use inhalers. Because they reduce inflammation and swelling in the airways, orally inhaled corticosteroids are an indispensable tool for the treatment of asthma. The market entry of combination drug inhalers that deliver a corticosteroid and a bronchodilator from the same inhaler are providing important options for both clinicians and patients.

Highlights

• Analyzes the market for corticosteroid drugs delivered via oral inhalers
• Assesses inhalation device technology for delivering corticosteroids orally, and evaluates product technology issues and evolving market factors
• Provides detailed assessments of orally inhaled corticosteroid product segments, growth prospects and market potential
• Provides market data and forecasts for orally inhaled corticosteroid drugs to 2022
• Profiles inhaled drug product market participants, their technology, product development activity, and business strategies
• Evaluates the impact of economic, technology, and regulatory factors on inhaled drug companies and their alliance partners

Table Of Contents

Orally Inhaled Corticosteroids to 2022
Executive Summary

Orally Inhaled Corticosteroid Market Overview

The Asthma Therapeutics Marketspace
Competing Drug Treatments
Corticosteroids and Asthma
Demand Drivers
Technology Factors
Competitive Landscape

Asthma Market Risks and Opportunities

Global Patient Demographics
Regional Market Drivers
Pediatric Asthma -the Growing Therapeutic Need

Inhaler Technologies for Delivering Corticosteroids

Dry Powder Inhalers
DPI Formulation Technology
Characteristics and Parameters
DPI Excipients and Packaging
Metered Dose Inhalers
MDI Device Selection Criteria
Ease-of-Use Factors
Nebulizers

Inhaled Corticosteroids - Product Analysis, Market Data and Forecasts

Beclomethasone, QVAR 40/80 (MDI)
Budesonide, Pulmicort (DPI)
Budesonide, Pulmicort (Nebulizer)
Generic Budesonide (Nebulizer)
Budesonide/Formoterol (Symbicort) Combination Drug Inhaler (MDI)
Ciclesonide, Alvesco (MDI)
Ciclesonide, Zetonna (MDI)
Flunisolide, Aerospan HFA (MDI)
Fluticasone, Arnuity Ellipta (DPI)
Fluticasone, Flovent HFA (MDI)
Fluticasone, Flovent Diskus50/100/250 (DPI)
Fluticasone/Salmeterol (Advair HFA) Combination Drug Inhaler (MDI)
Fluticasone/Salmeterol (Advair Diskus) Combination Drug Inhaler (DPI)
Fluticasone/Vilanterol (Breo Ellipta) Combination Drug Inhaler (DPI)
Mometasone, Asmanex HFA (MDI)
Mometasone, Asmanex Twisthaler (DPI)
Umeclidinium, Incruse Ellipta (DPI)
Umeclidinium/Vilanterol (Anora Ellipta) Combination Drug Inhaler (DPI)

Market Factors

Regulatory Issues
Patient Compliance
Prescribing Trends
Healthcare Economics
Regional Market Factors
Connected Devices

Market Sector Company Profiles

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Hepatorenal Syndrome Global Clinical Trials Review, H2, 2016

Hepatorenal Syndrome Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by GlobalData

Hepatorenal Syndrome Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Hepatorenal Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Hepatorenal ...

Hepatic Injury Global Clinical Trials Review, H2, 2016

Hepatic Injury Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by GlobalData

Hepatic Injury Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Hepatic Injury Global Clinical Trials Review, H2, 2016" provides an overview of Hepatic Injury clinical ...

Joint Pain Global Clinical Trials Review, H2, 2016

Joint Pain Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by GlobalData

Joint Pain Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Joint Pain Global Clinical Trials Review, H2, 2016" provides an overview of Joint Pain clinical trials ...


Download Unlimited Documents from Trusted Public Sources

Hormone and Therapy Market in Pakistan and the US

  • March 2017
    7 pages
  • Hormone  

    Therapy  

    Diabetes  

  • Pakistan  

    United States  

View report >

Insulin Market and Diabetes Statistics in the US

  • March 2017
    8 pages
  • Insulin  

    Antidiabetics  

    Diabetes  

  • United States  

View report >

HIV Antiviral Market in Sweden

  • March 2017
    4 pages
  • HIV Antiviral  

    Therapy  

  • Sweden  

View report >

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.